AHF Chart, page-11

First 11 Last

Share
Profile

Follow
winsonliang

343 Posts.

7

28/04/18

21:59

Post #: 32743609
Share

Originally posted by Amused observer ↑

Reality can be harsh at times...

Two things have pulled the price back and will continue to do so and that is the realisation of how executable the new strategy (the latest one not the one the month before) is, how long it will actually take to generate a positive cash-flow and what it actually will yield for both the company and shareholders, and secondly the abatement of the markets initial excitement over the announcement.

Looking at the charts for this one is fraught with danger except for very short term views as there is scant depth to any shift in price indicators due to unsustainable business drivers or missed targets in the past as @Grant62 has pointed out in another post.

It may also be in anticipation of the quarterly results due on Monday, which are going to painful.

Combine all the above and expect the price to go back to the mid-late teens until the company starts to actually deliver on promises and meets some financial performance targets, being tangible bottom line targets not intangible top line aspirations.

Expand

Originally posted by Amused observer ↑

Reality can be harsh at times...

Two things have pulled the price back and will continue to do so and that is the realisation of how executable the new strategy (the latest one not the one the month before) is, how long it will actually take to generate a positive cash-flow and what it actually will yield for both the company and shareholders, and secondly the abatement of the markets initial excitement over the announcement.

Looking at the charts for this one is fraught with danger except for very short term views as there is scant depth to any shift in price indicators due to unsustainable business drivers or missed targets in the past as @Grant62 has pointed out in another post.

It may also be in anticipation of the quarterly results due on Monday, which are going to painful.

Combine all the above and expect the price to go back to the mid-late teens until the company starts to actually deliver on promises and meets some financial performance targets, being tangible bottom line targets not intangible top line aspirations.

Expand

I know and understand your concern.
@Grant62 has done plenty of researches about the company even the industry compared to others.
both of your conclusion IMO is not sure about the future.
I believe change.
I am new in investing aus shares anyway.

AHF Price at posting: 20.5¢ Sentiment: None Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

NOX

Noxopharm gets HERACLES autoimmune trials started with first human doses

LDX

Lumos Diagnostics surges 140% on major US contract deal

IMU

Wednesday's HotCopper trends: Imugene cap raise, Lumos distribution deal | July 16

MGX

Mount Gibson gets into gold with 'attractive' $50M Central Tanami joint venture

First 11 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 4.2¢		Change 0.000(0.00%)		Mkt cap ! $31.21M

Open	High	Low	Value	Volume
4.2¢	4.2¢	4.2¢	$548	13.05K

Buyers (Bids)

No.	Vol.	Price($)
3	420731	4.1¢

Sellers (Offers)

Price($)	Vol.	No.
4.2¢	184047	2

View Market Depth

No.	Vol.	Price($)
3	420731	0.041
3	203626	0.040
1	1000000	0.039
1	100000	0.038
1	270297	0.037

Price($)	Vol.	No.
0.042	184047	2
0.043	250000	1
0.044	1457274	4
0.045	515583	4
0.046	393506	1

Last trade - 10.17am 16/07/2025 (20 minute delay)

AHF (ASX) Chart

AHF Chart, page-11

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

Noxopharm gets HERACLES autoimmune trials started with first human doses

Lumos Diagnostics surges 140% on major US contract deal

Wednesday's HotCopper trends: Imugene cap raise, Lumos distribution deal | July 16

Mount Gibson gets into gold with 'attractive' $50M Central Tanami joint venture

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

AHF Chart, page-11

Top Stories

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

Noxopharm gets HERACLES autoimmune trials started with first human doses

Lumos Diagnostics surges 140% on major US contract deal

Wednesday's HotCopper trends: Imugene cap raise, Lumos distribution deal | July 16

Mount Gibson gets into gold with 'attractive' $50M Central Tanami joint venture

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News